A

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

Frontiers in Pharmacology, vol. 12, pp. 693453

Abstract

Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy. Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical routines. Next-generation sequencing (NGS) technologies are emerging as a more comprehensive and time- and cost-effective approach in PGx. This review presents the main considerations for applying NGS in guiding drug treatment in clinical practice. It discusses both the advantages and the challenges of implementing NGS-based tests in PGx. Moreover, the limitations of each NGS platform are revealed, and the solutions for setting up and management of these technologies in clinical practice are addressed.

Authors 5

  1. Medical University of Białystok

    Affiliation as printed

    Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

    Department of Analysis and Bioanalysis of Medicines, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Bialystok, Poland

  2. Leiden University Medical Center

    Affiliation as printed

    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands

    Leiden Network of Personalized Therapeutics, Leiden, Netherlands

  3. Medical University of Białystok

    Affiliation as printed

    Department of Analysis and Bioanalysis of Medicines, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Bialystok, Bialystok, Poland

  4. Medical University of Białystok

    Affiliation as printed

    Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland

    Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland

  5. Leiden University Medical Center

    Affiliation as printed

    Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands

    Leiden Network of Personalized Therapeutics, Leiden, Netherlands

Cited by 65 stored of 65

No patents citing this paper on Lens.org (checked 2026-10-11).

References 103